Media

Corvidia’s latest news and press releases.

Corvidia Therapeutics Initiates Phase 2b Dose-Finding Study for Ziltivekimab

Waltham, MA, June 13, 2019 — Corvidia Therapeutics Inc., a clinical stage biotechnology company, announced today the initiation of patient screening for a Phase 2b dose-finding study of ziltivekimab. Previously known as COR-001, ziltivekimab is a proprietary anti-interleukin-6 ligand monoclonal antibody (anti-IL6 mAb), targeting residual inflammatory cardiovascular risk in patients living with advanced chronic kidney disease (CKD).

June 13th, 2019

DOWNLOAD NOW

Corvidia Therapeutics to Participate in 2019 Jefferies Global Healthcare Conference

Corvidia Therapeutics Inc., a clinical stage biotechnology company, today announced Marc de Garidel, chief executive officer will present in the Jefferies 2019 Global Healthcare Conference in New York City on Friday, June 7 at 9:30 am.

June 4th, 2019

DOWNLOAD NOW

Corvidia Therapeutics Announces Dr. Preston Klassen Joins its Board of Directors

Corvidia Therapeutics Inc., a clinical stage biotechnology company, today announced the appointment of Dr. Preston Klassen, M.D., M.H.S. to its Board of Directors…

May 21st 2019

DOWNLOAD NOW

Corvidia Therapeutics Secures $60 Million in Series B Funding

Corvidia Therapeutics secures $60 million in series B funding to accelerate clinical work starting with 25th of April 2018…

APR 25TH 2018

DOWNLOAD NOW

Corvidia Therapeutics Appoints Marc de Garidel as Chief Executive Officer

Marc de Garidel was appointed Chief Executive Officer at Corvidia Therapeutics starting with 29th of March 2018…

MAR 29TH 2018

DOWNLOAD NOW

Sylvie Gregoire Appointed as Chair of the Board of Directors

Sylvie Gregoire is Appointed as Chair of the Board of Directors at Corvidia Therapeutics starting with the 14th of June 2016…

JUN 14TH 2016

DOWNLOAD NOW

Corvidia Therapeutics Raises 26M Series a Financing

Corvidia Therapeutics announces the milestone of raising 26m series a financing starting with the 16th of February 2016…

FEB 16TH 2016

DOWNLOAD NOW

OUR LATEST PRESS RELEASES

Media Contact

Media Contact information

McDougall Communications on behalf of Corvidia TX
Elizabeth Harness
Tel: +1 (585) 441-0202